{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:59:03Z","timestamp":1791176343884,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.bpg.2005.10.002","type":"journal-article","created":{"date-parts":[[2006,3,20]],"date-time":"2006-03-20T02:09:49Z","timestamp":1142820589000},"page":"211-226","source":"Crossref","is-referenced-by-count":131,"title":["Molecular pathogenesis of pancreatic cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Anirban","family":"Maitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph H.","family":"Hruban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2005.10.002_bib1","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Databases: Incidence\u2014SEER 11 Regs + AK Public-Use, Nov 2003 Sub for Expanded Races (1992-2001) and Incidence\u2014SEER 11 Regs Public-Use, Nov 2003 Sub for Hispanics (1992-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission, 2004."},{"issue":"1","key":"10.1016\/j.bpg.2005.10.002_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.bpg.2005.10.002_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2005.10.002_bib4","unstructured":"Hruban RH, Klimstra DS, Pitman MB. Atlas of tumor pathology. Tumors of the pancreas. Fourth Series edn. Washington, DC: Armed Forces Institute of Pathology, 2006."},{"key":"10.1016\/j.bpg.2005.10.002_bib5","first-page":"4670","article-title":"Allelotype of pancreatic adenocarcinoma using xenograft enrichment","volume":"55","author":"Hahn","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng0994-27","article-title":"Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma","volume":"8","author":"Caldas","year":"1994","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.bpg.2005.10.002_bib7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0002-9440(10)63485-2","article-title":"BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets","volume":"163","author":"Calhoun","year":"2003","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.bpg.2005.10.002_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/73536","article-title":"Mutations truncating the EP300 acetylase in human cancers","volume":"24","author":"Gayther","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpg.2005.10.002_bib9","first-page":"5329","article-title":"Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas","volume":"58","author":"Goggins","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":"DPC4, a candidate tumor-suppressor gene at human chromosome 18q21.1","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib11","first-page":"994","article-title":"Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers","volume":"63","author":"Hempen","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib12","first-page":"619","article-title":"MTS-1 (CDKN2) tumor-suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines","volume":"10","author":"Liu","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.bpg.2005.10.002_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/gast.1996.v110.pm8613012","article-title":"Frequent codeletion of p16\/MTS1 and p15\/MTS2 and genetic alterations in p16\/MTS1 in pancreatic tumors","volume":"110","author":"Naumann","year":"1996","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2005.10.002_bib14","first-page":"3025","article-title":"p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions","volume":"54","author":"Redston","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib15","first-page":"1731","article-title":"Tumor-suppressive pathways in pancreatic carcinoma","volume":"57","author":"Rozenblum","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib16","first-page":"3126","article-title":"Abrogation of the Rb\/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas","volume":"57","author":"Schutte","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib17","first-page":"2339","article-title":"Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor-suppressor gene","volume":"58","author":"Su","year":"1998","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0002-9440(10)65440-5","article-title":"Germline and somatic mutations of the STK11\/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers","volume":"154","author":"Su","year":"1999","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib19","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1073\/pnas.051484398","article-title":"ACVR1B (ALK4, activin receptor type 1B) gene mutation in pancreatic carcinoma","volume":"98","author":"Su","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpg.2005.10.002_bib20","first-page":"4177","article-title":"Human mitogen-activated protein kinase kinase 4 as a candidate tumor-suppressor","volume":"57","author":"Teng","year":"1997","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.bpg.2005.10.002_bib21","first-page":"2585","article-title":"Fanconi anemia gene mutations in young-onset pancreatic cancer","volume":"63","author":"van der Heijden","year":"2003","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.bpg.2005.10.002_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9440(10)63329-9","article-title":"Functional defects in the fanconi anemia pathway in pancreatic cancer cells","volume":"165","author":"van der Heijden","year":"2004","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib23","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/1078-0432.CCR-1121-3","article-title":"Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors","volume":"10","author":"Iacobuzio-Donahue","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00000658-200212000-00005","article-title":"CDKN2A germline mutations in familial pancreatic cancer","volume":"236","author":"Bartsch","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2005.10.002_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/bjc.1990.209","article-title":"Systemic cancer and the FAMMM syndrome","volume":"61","author":"Bergman","year":"1990","journal-title":"Br J Cancer"},{"issue":"15","key":"10.1016\/j.bpg.2005.10.002_bib26","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","article-title":"High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families","volume":"92","author":"Borg","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"10 Pt 1","key":"10.1016\/j.bpg.2005.10.002_bib27","first-page":"3598","article-title":"Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A\/p16 (p16-leiden)","volume":"9","author":"de vos tot Nederveen Cappel","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.bpg.2005.10.002_bib28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199510123331504","article-title":"Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations","volume":"333","author":"Goldstein","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2005.10.002_bib29","first-page":"409","article-title":"Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations","volume":"60","author":"Lal","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bpg.2005.10.002_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.10159","article-title":"Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma\u2013pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome","volume":"94","author":"Lynch","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.bpg.2005.10.002_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.139.8.1019","article-title":"Pancreatic carcinoma surveillance in patients with familial melanoma","volume":"139","author":"Parker","year":"2003","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","article-title":"Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)","volume":"87","author":"Vasen","year":"2000","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.bpg.2005.10.002_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/modpathol.3800377","article-title":"Concordant loss of MTAP and p16\/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion","volume":"18","author":"Hustinx","year":"2005","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.bpg.2005.10.002_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4161\/cbt.4.1.1380","article-title":"Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy","volume":"4","author":"Hustinx","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bpg.2005.10.002_bib35","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.2047879","article-title":"Identification of p53 as a sequence-specific DNA-binding protein","volume":"252","author":"Kern","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bpg.2005.10.002_bib36","first-page":"2527","article-title":"DPC4 gene in various tumor types","volume":"56","author":"Schutte","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9440(10)64703-7","article-title":"Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation","volume":"156","author":"Wilentz","year":"2000","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.bpg.2005.10.002_bib38","first-page":"545","article-title":"K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization","volume":"143","author":"Hruban","year":"1993","journal-title":"Am J Pathol"},{"issue":"24","key":"10.1016\/j.bpg.2005.10.002_bib39","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1073\/pnas.0402932101","article-title":"High-resolution characterization of the pancreatic adenocarcinoma genome","volume":"101","author":"Aguirre","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpg.2005.10.002_bib40","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","article-title":"Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorgenicity by antisense RNA","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bpg.2005.10.002_bib41","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1006\/bbrc.1996.1280","article-title":"Isolation of DNA sequences amplified at chromosome 19q13.1\u2013q13.2 including the AKT2 locus in human pancreatic cancer","volume":"225","author":"Miwa","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bpg.2005.10.002_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R","article-title":"Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas","volume":"21","author":"Ruggeri","year":"1998","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.bpg.2005.10.002_bib43","first-page":"3135","article-title":"Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene","volume":"57","author":"Wallrapp","year":"1997","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bpg.2005.10.002_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergencyto.2005.01.009","article-title":"Genome-wide aberrations in pancreatic adenocarcinoma","volume":"161","author":"Nowak","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1593\/neo.04586","article-title":"Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer","volume":"7","author":"Bashyam","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.bpg.2005.10.002_bib46","first-page":"1501","article-title":"Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+","volume":"152","author":"Goggins","year":"1998","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib47","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65035-3","article-title":"Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity","volume":"156","author":"Wilentz","year":"2000","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib48","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1073\/pnas.051484398","article-title":"ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma","volume":"98","author":"Su","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.bpg.2005.10.002_bib49","first-page":"3139","article-title":"Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability","volume":"61","author":"Yamamoto","year":"2001","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.bpg.2005.10.002_bib50","first-page":"2536","article-title":"Prognostic value of microsatellite instability in resectable pancreatic cancer","volume":"8","author":"Nakata","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.bpg.2005.10.002_bib51","first-page":"997","article-title":"Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients","volume":"10","author":"Nakata","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bpg.2005.10.002_bib52","first-page":"5360","article-title":"Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas","volume":"56","author":"Goggins","year":"1996","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.bpg.2005.10.002_bib53","first-page":"3789","article-title":"Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%","volume":"62","author":"Murphy","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng0597-17","article-title":"Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients","volume":"16","author":"Ozcelik","year":"1997","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.bpg.2005.10.002_bib55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/0008-5472.383.65.2","article-title":"Germ line Fanconi anemia complementation group C mutations and pancreatic cancer","volume":"65","author":"Couch","year":"2005","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib56","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)64432-X","article-title":"Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia","volume":"161","author":"van Heek","year":"2002","journal-title":"Am J Pathol"},{"issue":"24","key":"10.1016\/j.bpg.2005.10.002_bib57","first-page":"8614","article-title":"Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies","volume":"63","author":"Iacobuzio-Donahue","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib58","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0002-9440(10)62551-5","article-title":"Discovery of novel tumor markers of pancreatic cancer using global gene expression technology","volume":"160","author":"Iacobuzio-Donahue","year":"2002","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.bpg.2005.10.002_bib59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9440(10)63911-9","article-title":"Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays","volume":"162","author":"Iacobuzio-Donahue","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2005.10.002_bib60","series-title":"Expression Profiling of Human Tumors: Diagnostic and Research Applications","first-page":"257","article-title":"Expression profiling of pancreatic ductal adenocarcinoma","author":"Iacobuzio-Donahue","year":"2003"},{"issue":"3","key":"10.1016\/j.bpg.2005.10.002_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00125480-200305000-00002","article-title":"Gene expression in neoplasms of the pancreas: applications to diagnostic pathology","volume":"10","author":"Iacobuzio-Donahue","year":"2003","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"10.1016\/j.bpg.2005.10.002_bib62","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.bpg.2005.10.002_bib63","first-page":"238","article-title":"Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases","volume":"11","author":"McCarthy","year":"2003","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.bpg.2005.10.002_bib64","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00002371-200007000-00011","article-title":"Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma","volume":"23","author":"Hassan","year":"2000","journal-title":"J Immunother"},{"issue":"3","key":"10.1016\/j.bpg.2005.10.002_bib65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.20031435","article-title":"Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients","volume":"200","author":"Thomas","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.bpg.2005.10.002_bib66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)64353-2","article-title":"Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion","volume":"160","author":"Iacobuzio-Donahue","year":"2002","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","article-title":"Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions","volume":"25","author":"Hruban","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpg.2005.10.002_bib68","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF01968012","article-title":"Zur kenntnis der Genese des Adenokarzinoms und Karzinoms des Pankreas","volume":"180","author":"Hulst","year":"1905","journal-title":"Virchows Arch (B)"},{"key":"10.1016\/j.bpg.2005.10.002_bib69","first-page":"2969","article-title":"Progression model for pancreatic cancer","volume":"6","author":"Hruban","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.bpg.2005.10.002_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-199802000-00003","article-title":"Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas","volume":"22","author":"Brat","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1092-9134(98)80020-8","article-title":"Progression of atypical ductal hyperplasia\/carcinoma in situ of the pancreas to invasive adenocarcinoma","volume":"2","author":"Brockie","year":"1998","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.bpg.2005.10.002_bib72","first-page":"1291","article-title":"Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas","volume":"145","author":"Boschman","year":"1994","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib73","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0002-9440(10)65047-X","article-title":"BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications","volume":"156","author":"Goggins","year":"2000","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.bpg.2005.10.002_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0002-9440(10)64520-8","article-title":"Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma","volume":"157","author":"Heinm\u00f6ller","year":"2000","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib75","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0002-9440(10)64123-5","article-title":"Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis","volume":"158","author":"L\u00fcttges","year":"2001","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.bpg.2005.10.002_bib76","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.MP.0000086072.56290.FB","article-title":"Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray","volume":"16","author":"Maitra","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpg.2005.10.002_bib77","first-page":"2140","article-title":"p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma","volume":"57","author":"Moskaluk","year":"1997","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.bpg.2005.10.002_bib78","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/00000478-200312000-00001","article-title":"p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis","volume":"27","author":"Rosty","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib79","first-page":"515","article-title":"K-ras mutation in focal proliferative lesions of human pancreas","volume":"7","author":"Terhune","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpg.2005.10.002_bib80","first-page":"2002","article-title":"Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression","volume":"60","author":"Wilentz","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2005.10.002_bib81","first-page":"4740","article-title":"Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression","volume":"58","author":"Wilentz","year":"1998","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib82","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)65083-3","article-title":"Genetic progression and divergence in pancreatic carcinoma","volume":"156","author":"Yamano","year":"2000","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.bpg.2005.10.002_bib83","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bpg.2005.10.002_bib84","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bpg.2005.10.002_bib85","first-page":"2005","volume":"1975","author":"Elkin","year":"1999","journal-title":"The effect of changes in tumor size on breast carcinoma survival in the US"},{"issue":"10","key":"10.1016\/j.bpg.2005.10.002_bib86","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00000478-199810000-00010","article-title":"K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium","volume":"22","author":"Westra","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.bpg.2005.10.002_bib87","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0002-9440(10)62563-1","article-title":"Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations","volume":"160","author":"Abraham","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2005.10.002_bib88","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0002-9440(10)63008-8","article-title":"Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC\/beta-catenin pathway and chromosome 11p","volume":"159","author":"Abraham","year":"2001","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.bpg.2005.10.002_bib89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nmeth713","article-title":"LigAmp for sensitive detection of single-nucleotide differences","volume":"1","author":"Shi","year":"2004","journal-title":"Nat Methods"},{"issue":"7015","key":"10.1016\/j.bpg.2005.10.002_bib90","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature03100","article-title":"Tissue repair and stem cell renewal in carcinogenesis","volume":"432","author":"Beachy","year":"2004","journal-title":"Nature"},{"issue":"6960","key":"10.1016\/j.bpg.2005.10.002_bib91","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01972","article-title":"Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours","volume":"425","author":"Berman","year":"2003","journal-title":"Nature"},{"issue":"6960","key":"10.1016\/j.bpg.2005.10.002_bib92","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature02009","article-title":"Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis","volume":"425","author":"Thayer","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2005.10.002_bib93","unstructured":"Canto MI, Goggins M, Yeo CJ, et al., Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. (Submitted)."},{"issue":"7","key":"10.1016\/j.bpg.2005.10.002_bib94","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1542-3565(04)00244-7","article-title":"Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach","volume":"2","author":"Canto","year":"2004","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691805001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691805001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T20:17:19Z","timestamp":1683404239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691805001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1521691805001551"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2005.10.002","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}